{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:21:21Z","timestamp":1775856081424,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0411-z","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T10:22:56Z","timestamp":1484648576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4542-1290","authenticated-orcid":false,"given":"Petter-Arnt","family":"Hals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"411_CR1","first-page":"C004816","volume":"1","author":"F Taylor","year":"2013","unstructured":"Taylor F, Huffman MD, Macedo AF, Moore THM, Burke M, Davey Smith G, Ward K, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane db syst rev. 2013;1:C004816.","journal-title":"Cochrane db syst rev"},{"issue":"Suppl","key":"411_CR2","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","volume":"50","author":"JD Horton","year":"2009","unstructured":"Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res. 2009;50(Suppl):S172\u20137.","journal-title":"J Lipid Res"},{"key":"411_CR3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MOL.0b013e328353ef1d","volume":"23","author":"B Hewing","year":"2012","unstructured":"Hewing B, Fisher EA. Rationale for cholesteryl ester transfer protein inhibition. Curr Opin Lipidol. 2012;23:372\u20136.","journal-title":"Curr Opin Lipidol"},{"key":"411_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40256-013-0030-7","volume":"13","author":"CM Perry","year":"2013","unstructured":"Perry CM. Lomitapide: a review of its use in adults with homozygous familial hypercholesterolemia. Am J Cardiovasc Drugs. 2013;13:285\u201396.","journal-title":"Am J Cardiovasc Drugs"},{"key":"411_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2125.2012.04469.x","volume":"76","author":"ST Crooke","year":"2013","unstructured":"Crooke ST, Geary RS. Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B. Br J Clin Pharmacol. 2013;76:269\u201376.","journal-title":"Br J Clin Pharmacol"},{"key":"411_CR6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-2275(20)38424-8","volume":"29","author":"WS Harris","year":"1988","unstructured":"Harris WS, Connor WE, Alam N, Illingworth DR. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res. 1988;29:1451\u201360.","journal-title":"J Lipid Res"},{"key":"411_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2013.10.014","volume":"232","author":"D Tousoulis","year":"2014","unstructured":"Tousoulis D, Plastiras A, Siasos G, Oikonomou E, Verveniotis A, Kokkou E, Maniatis K, Gouliopoulos N, Miliou A, Paraskevopoulos T, Stefanadis C. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis. 2014;232:10\u20136.","journal-title":"Atherosclerosis"},{"key":"411_CR8","doi-asserted-by":"crossref","first-page":"791978","DOI":"10.1155\/2015\/791978","volume":"2015","author":"M Zanetti","year":"2015","unstructured":"Zanetti M, Grillo A, Losurdo P, Panizon E, Mearelli F, Cattin L, Barazzoni R, Carretta R. Omega-3 polyunsaturated fatty acids: structural and functional effects on the vascular wall. Biomed Res Int. 2015;2015:791978.","journal-title":"Biomed Res Int"},{"key":"411_CR9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/jn\/126.6.1515","volume":"126","author":"WL Blok","year":"1996","unstructured":"Blok WL, Katan MB, van der Meer JW. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr. 1996;126:1515\u201333.","journal-title":"J Nutr"},{"key":"411_CR10","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","volume":"83","author":"PC Calder","year":"2006","unstructured":"Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:1505S\u201319.","journal-title":"Am J Clin Nutr"},{"key":"411_CR11","doi-asserted-by":"crossref","first-page":"50i","DOI":"10.1016\/j.amjcard.2005.12.027","volume":"98","author":"JA Reiffel","year":"2006","unstructured":"Reiffel JA, McDonald A. Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol. 2006;98:50i\u201360.","journal-title":"Am J Cardiol"},{"key":"411_CR12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.CIR.88.2.523","volume":"88","author":"MC Morris","year":"1993","unstructured":"Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993;88:523\u201333.","journal-title":"Circulation"},{"key":"411_CR13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/archinte.1993.00410120017003","volume":"153","author":"LJ Appel","year":"1993","unstructured":"Appel LJ, Miller 3rd ER, Seidler AJ, Whelton PK. Does supplementation of diet with \u2018fish oil\u2019 reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993;153:1429\u201338.","journal-title":"Arch Intern Med"},{"key":"411_CR14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/ajh\/hpu024","volume":"27","author":"PE Miller","year":"2014","unstructured":"Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens. 2014;27:885\u201396.","journal-title":"Am J Hypertens"},{"key":"411_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.phrs.2007.01.013","volume":"55","author":"WS Harris","year":"2007","unstructured":"Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res. 2007;55:217\u201323.","journal-title":"Pharmacol Res"},{"key":"411_CR16","doi-asserted-by":"crossref","first-page":"71i","DOI":"10.1016\/j.amjcard.2005.12.029","volume":"98","author":"H Bays","year":"2006","unstructured":"Bays H. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol. 2006;98:71i\u20136.","journal-title":"Am J Cardiol"},{"key":"411_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/14779072.6.3.391","volume":"6","author":"HE Bays","year":"2008","unstructured":"Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther. 2008;6:391\u2013409.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"411_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11745-010-3472-6","volume":"46","author":"B Winther","year":"2011","unstructured":"Winther B, Hoem N, Berge K, Reubsaet L. Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba. Lipids. 2011;46:25\u201336.","journal-title":"Lipids"},{"key":"411_CR19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1113\/jphysiol.1932.sp002899","volume":"75","author":"CH Best","year":"1932","unstructured":"Best CH, Huntsman ME. The effects of the components of lecithine upon deposition of fat in the liver. J Physiol. 1932;75:405\u201312.","journal-title":"J Physiol"},{"key":"411_CR20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3945\/ajcn.2009.28456","volume":"91","author":"JE Lee","year":"2010","unstructured":"Lee JE, Jacques PF, Dougherty L, Selhub J, Giovannucci E, Zeisel SH, Cho E. Are dietary choline and betaine intakes determinants of total homocysteine concentration? Am J Clin Nutr. 2010;91:1303\u201310.","journal-title":"Am J Clin Nutr"},{"key":"411_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.ATV.4.3.270","volume":"4","author":"DR Illingworth","year":"1984","unstructured":"Illingworth DR, Harris WS, Connor WE. Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis. 1984;4:270\u20135.","journal-title":"Arteriosclerosis"},{"key":"411_CR22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00043798-199710000-00011","volume":"4","author":"WS Harris","year":"1997","unstructured":"Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997;4:385\u201391.","journal-title":"J Cardiovasc Risk"},{"key":"411_CR23","first-page":"1","volume":"94","author":"C Wang","year":"2004","unstructured":"Wang C, Chung M, Lichtenstein A, Balk E, Kupelnick B, DeVine D, Lawrence A, Lau J. Effects of omega-3 fatty acids on cardiovascular disease. Evid Rep Technol Assess (Summ). 2004;94:1\u20138.","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"411_CR24","volume-title":"Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Evidence Report\/Technology Assessment No 223 (Prepared by the Brown Evidence-based Practice Center under Contract No 290-2015-00002-I) AHRQ Publication No 16-E002-EF","author":"EM Balk","year":"2016","unstructured":"Balk EM, Adam GP, Langberg V, Halladay C, Chung M, Lin L, Robertson S, Yip A, Steele D, Smith BT, Lau J, Lichtenstein AH, Trikalinos TA. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Evidence Report\/Technology Assessment No 223 (Prepared by the Brown Evidence-based Practice Center under Contract No 290-2015-00002-I) AHRQ Publication No 16-E002-EF. Rockville: Agency for Healthcare Research and Quality; 2016."},{"key":"411_CR25","first-page":"010","volume":"S13","author":"X Wang","year":"2015","unstructured":"Wang X, Wang B, Sun G, Wu J, Liu Y, Wang Y, Xiao XF. Dysglycemia and dyslipidemia models in nonhuman primates: part I. Model of naturally occurring diabetes. J Diabetes Metab. 2015;S13:010.","journal-title":"J Diabetes Metab"},{"key":"411_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12872-015-0133-y","volume":"15","author":"H Gu","year":"2015","unstructured":"Gu H, Liu Y, Mei S, Wang B, Sun G, Wang X, Xiao Y, Staup M, Gregoire FM, Chng K, Wang YJ. Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes. BMC Cardiovasc Disord. 2015;15:141.","journal-title":"BMC Cardiovasc Disord"},{"key":"411_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","volume":"39","author":"WS Harris","year":"2004","unstructured":"Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39:212\u201320.","journal-title":"Prev Med"},{"key":"411_CR28","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1002\/j.1460-2075.1986.tb04675.x","volume":"5","author":"C Cladaras","year":"1986","unstructured":"Cladaras C, Hadzopoulou-Cladaras M, Nolte RT, Atkinson D, Zannis VI. The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms. Embo J. 1986;5:3495\u2013507.","journal-title":"Embo J"},{"key":"411_CR29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0022-2275(20)30267-4","volume":"42","author":"JP Segrest","year":"2001","unstructured":"Segrest JP, Jones MK, De Loof H, Dashti N. Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res. 2001;42:1346\u201367.","journal-title":"J Lipid Res"},{"key":"411_CR30","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/S0006-3495(97)78264-X","volume":"73","author":"JC Phillips","year":"1997","unstructured":"Phillips JC, Wriggers W, Li Z, Jonas A, Schulten K. Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. Biophys J. 1997;73:2337\u201346.","journal-title":"Biophys J"},{"key":"411_CR31","first-page":"318","volume":"6","author":"V Gogonea","year":"2015","unstructured":"Gogonea V. Structural Insights into High Density Lipoprotein: Old Models and New Facts. Front Pharmacol. 2015;6:318.","journal-title":"Front Pharmacol"},{"key":"411_CR32","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1016\/S0021-9258(18)63614-2","volume":"244","author":"WV Brown","year":"1969","unstructured":"Brown WV, Levy RI, Fredrickson DS. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem. 1969;244:5687\u201394.","journal-title":"J Biol Chem"},{"key":"411_CR33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/ATVBAHA.110.221846","volume":"31","author":"HN Ginsberg","year":"2011","unstructured":"Ginsberg HN, Brown WV. Apolipoprotein CIII: 42 Years Old and Even More Interesting. Arterioscl Throm Vas. 2011;31:471\u20133.","journal-title":"Arterioscl Throm Vas"},{"key":"411_CR34","first-page":"CD003205","volume":"1","author":"J Hartweg","year":"2009","unstructured":"Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane db syst rev. 2009;1:CD003205.","journal-title":"Cochrane db syst rev"},{"key":"411_CR35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1248\/bpb.24.579","volume":"24","author":"K Tsutsumi","year":"2001","unstructured":"Tsutsumi K, Hagi A, Inoue Y. The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. Biol Pharm Bull. 2001;24:579\u201381.","journal-title":"Biol Pharm Bull"},{"key":"411_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1194\/jlr.M019927","volume":"53","author":"W Yin","year":"2012","unstructured":"Yin W, Carballo-Jane E, McLaren DG, Mendoza VH, Gagen K, Geoghagen NS, McNamara LA, Gorski JN, Eiermann GJ, Petrov A, et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res. 2012;53:51\u201365.","journal-title":"J Lipid Res"},{"key":"411_CR37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ilar\/ilt040","volume":"54","author":"SD Tardif","year":"2013","unstructured":"Tardif SD, Coleman K, Hobbs TR, Lutz C. IACUC review of nonhuman primate research. Ilar J. 2013;54:234\u201345.","journal-title":"Ilar J"},{"key":"411_CR38","unstructured":"Weatherall D. The use of non-human primates in research. The Royal Society 2006. https:\/\/royalsociety.org\/topics-policy\/publications\/2006\/weatherall-report\/ . Accessed 7 June 2016."},{"key":"411_CR39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","volume":"259","author":"PJ Barter","year":"2006","unstructured":"Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel. J Intern Med. 2006;259:247\u201358.","journal-title":"J Intern Med"},{"key":"411_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2006.02.012","volume":"189","author":"EM Balk","year":"2006","unstructured":"Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19\u201330.","journal-title":"Atherosclerosis"},{"key":"411_CR41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","volume":"308","author":"EC Rizos","year":"2012","unstructured":"Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308:1024\u201333.","journal-title":"JAMA"},{"key":"411_CR42","first-page":"420","volume":"9","author":"R Bunea","year":"2004","unstructured":"Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev. 2004;9:420\u20138.","journal-title":"Altern Med Rev"},{"key":"411_CR43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000107","volume":"3","author":"JM Lobraico","year":"2015","unstructured":"Lobraico JM, DiLello LC, Butler AD, Cordisco ME, Petrini JR, Ahmadi R. Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial. BMJ Open Diabetes Res Care. 2015;3, e000107.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"411_CR44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nutres.2013.12.003","volume":"34","author":"K Berge","year":"2014","unstructured":"Berge K, Musa-Veloso K, Harwood M, Hoem N, Burri L. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Nutr Res. 2014;34:126\u201333.","journal-title":"Nutr Res"},{"key":"411_CR45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.5114\/aoms.2016.59923","volume":"12","author":"AF Cicero","year":"2016","unstructured":"Cicero AF, Rosticci M, Morbini M, Cagnati M, Grandi E, Parini A, Borghi C. Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial. Arch Med Sci. 2016;12:507\u201312.","journal-title":"Arch Med Sci"},{"key":"411_CR46","unstructured":"No authors listed. Krill oil Monograph. Altern Med Rev. 2010;15:84\u20136."},{"key":"411_CR47","doi-asserted-by":"publisher","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to choline and contribution to normal lipid metabolism (ID 3186), maintenance of normal liver function (ID 1501), contribution to normal homocysteine metabolism (ID 3090), maintenance of normal neurological function (ID 1502), contribution to normal cognitive function (ID 1502), and brain and neurological development (ID 1503) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA Journal 2011;9(4):2056. [23 pp.]. doi: 10.2903\/j.efsa.2011.2056 . Available online: http:\/\/www.efsa.europa.eu\/efsajournal .","DOI":"10.2903\/j.efsa.2011.2056"},{"key":"411_CR48","unstructured":"Harris WS, Von Schacky C, Park Y. Standardizing methods for assessing omega-3 fatty acid biostatus. In: MacNamara RK, editor. The Omega-3 fatty acid deficiency syndrome. Nova Science Publishers Ltd; 2013. p. 385\u201398."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T22:17:22Z","timestamp":1658441842000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0411-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0411-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]},"article-number":"11"}}